impact factor, citescore
logo
 

Clinical and Experimental Rheumatology is a monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983. The journal includes annual monothematic issues on the following topics:

The monothematic issue on Myositis is also the official organ of the International Myositis Society (iMyoS, https://imyos.org).

Articles submitted on these topics, once accepted are published ahead-of-print online, and subsequently included in the correspondent monothematic issue.

Editor-in-Chief
Stefano Bombardieri, MD

Environmental Rheumatology

LER & CER: Letter to the Editor Rheumatology

Letter to Editor Rheumatology: Commentaries and Controversies (LER) has been an online forum for a stronger voice and a wider audience for critical and dissenting views in rheumatology and related disciplines. It has joined forces with Clinical and Experimental Rheumatology to achieve the deserved wider audience.

Letters can be submitted solely to: https://www.clinexprheumatol.org, please read Authors’ Guidelines.

Page charge

A page charge of €130.00 will be assessed for all articles published. Instructions for payment will be sent to authors along with the proofs. There is no charge for solicited articles.

Education and CME

 

last archive

Quality

The 5 most viewed PDFs in the last 7 days
in press from 6 months ago (One year in review excluded)

From 03/06/2025 to 10/06/2025

CER18234
Free to view
43 click

Comparison of the efficacy of Janus kinase inhibitors and adalimumab in rheumatoid arthritis: a meta-analysis
Q. Zhou, S. Zhu, S. Dai, Q. Wu, J. Zheng, H. Zhu, W. Yang

Rheumatology Abstract

 

CER18707
Free to view
40 click

The long journey of artificial intelligence in medicine: an overview
E. Grossi

Rheumatology Abstract

 

CER18806
Free to view
38 click

Exploring the ‘risk’: Comments on the FAERS data regarding the safety of JAK inhibitors by Mikaeili et al.
E. Bilgin

Rheumatology Abstract

 

CER18563
Free to view
34 click

Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases
F. Buzzulini, D. Villalta, G. Previtali, M.G. Alessio, G. Cafaro, E. Bartoloni, R. Gerli, N. Bizzaro
Collaborator/s: A. Ghirardello, M. Zen, P. Migliorini, O. Bistoni, C. Perricone, F. Topini, F. Franceschini, I. Cavazzana, S. Piantoni, M. Fredi

Rheumatology Abstract

 

CER18297
Free to view
31 click

Clinical outcomes in cancer patients with immune checkpoint inhibitor-induced arthritis treated with methotrexate: a retrospective longitudinal monocentric pilot study
E. Hysa, A. Casabella, N. Iandolino, E. Gotelli, C. Genova, E.T. Tanda, C. Pizzorni, V. Smith, A. Sulli, M. Cutolo, S. Paolino

Rheumatology Abstract

 

The 5 most viewed Abstracts in the last 7 days
in press from 6 months ago (One year in review excluded)

From 03/06/2025 to 10/06/2025

CER17941
Free to view
225 click

The expression of Siglec-10 on naive B cells is involved in the pathology of systemic lupus erythematosus
B. Ju, J. Luo, N. Hu, J. Zhang, L. Zhu, Q. Li, Y. Wang, J. Huang, Q. An, Q. Xu, Z. Hao, D. Pu, X. Lv, X. Li, Y. Huo, B. Zhang, L. He

Rheumatology Abstract

 

CER18199
137 click

Macrophage requirements for abatacept response in rheumatoid arthritis
B. De Maleprade, B. Gérard, P. Brevet, G. Riou, S. Candon, O. Boyer, O. Vittecoq, T. Lequerré, M. Fréret

Rheumatology Abstract

 

CER18812
Free to view
125 click

Anti-CD19 chimeric antigen receptor T cell therapy achieved rapid and sustained remission in a patient with systemic lupus erythematosus-associated refractory immune thrombocytopenia
X. Zhao, L. Zhang, X. Zhang, X. Liu, Y. Zhang, Y. Liu, X. Tian, X. Men, L. Lv, Y. Feng, J. Song, T. Xie, S. Liu, Y. Zhang

Rheumatology Abstract

 

CER18557
122 click

Lung involvement in psoriatic arthritis patients: cross-sectional study on prevalence, clinical characteristics, and risk factors of a neglected comorbidity
B. Monosi, I. Cristiano, E. Capparelli, A. Cito, P. Conigliaro, G. Lepri, S. Guiducci, E. Puxeddu, P. Rogliani, F. Iannone, G. Lopalco, M.S. Chimenti

Rheumatology Abstract

 

CER18806
Free to view
120 click

Exploring the ‘risk’: Comments on the FAERS data regarding the safety of JAK inhibitors by Mikaeili et al.
E. Bilgin

Rheumatology Abstract